Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global neurothrombectomy devices market 3600 synopsis, 2018 – 2032
2.1.1 Regional trends
2.1.2 Product type trends
2.1.3 End-use trends
Chapter 3 Neurothrombectomy Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Technology landscape
3.3 Regulatory landscape
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Increasing prevalence of ischemic stroke
3.4.1.2 Technological advancements in neurothrombectomy devices
3.4.1.3 Increasing investments in research and development
3.4.1.4 Rising awareness regarding neurological conditions
3.4.2 Industry pitfalls & challenges
3.4.2.1 High cost of devices
3.4.2.2 Stringent regulatory scenario
3.5 Growth potential analysis
3.5.1 By product type
3.5.2 By end-use
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic outlook matrix, 2023
Chapter 5 Neurothrombectomy Devices Market Size and Forecast, By Product Type, 2018-2032 (USD Million)
5.1 Key trends, by product type
5.2 Stent retrievers
5.3 Aspiration devices
5.4 Snares
5.5 Continuous flush catheter
Chapter 6 Neurothrombectomy Devices Market Size and Forecast, By End-use, 2018-2032 (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals and clinics
6.3 Ambulatory surgical centers (ASCs)
6.4 Other end users
Chapter 7 Neurothrombectomy Devices Market Size and Forecast, By Region, 2018-2032 (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Rest of Middle East & Africa
Chapter 8 Company Profiles
8.1 Medtronic Plc
8.2 Stryker Corporation
8.3 Penumbra, Inc.
8.4 Johnson & Johnson
8.5 MicroVention, Inc (Terumo Corporation)
8.6 Acandis GmbH
8.7 Phenox Inc.(Wallaby Medical)
8.8 Vesalio, LLC
8.9 AngioDynamics, Inc.
8.10 Abbott Laboratories
8.11 Edward Lifesciences Corporation
8.12 Boston Scientific Corporation
